Cargando…

Lanadelumab for hereditary angioedema

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081937/
https://www.ncbi.nlm.nih.gov/pubmed/35592365
http://dx.doi.org/10.18773/austprescr.2022.017
_version_ 1784703101706436608
collection PubMed
description
format Online
Article
Text
id pubmed-9081937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-90819372022-05-18 Lanadelumab for hereditary angioedema Aust Prescr New Drugs NPS MedicineWise 2022-03-04 2022-04 /pmc/articles/PMC9081937/ /pubmed/35592365 http://dx.doi.org/10.18773/austprescr.2022.017 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Lanadelumab for hereditary angioedema
title Lanadelumab for hereditary angioedema
title_full Lanadelumab for hereditary angioedema
title_fullStr Lanadelumab for hereditary angioedema
title_full_unstemmed Lanadelumab for hereditary angioedema
title_short Lanadelumab for hereditary angioedema
title_sort lanadelumab for hereditary angioedema
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081937/
https://www.ncbi.nlm.nih.gov/pubmed/35592365
http://dx.doi.org/10.18773/austprescr.2022.017